JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, cilt.136, sa.4, ss.1038-1047, 2008 (SCI-Expanded)
Background: Prophylactic treatment with carbamazepine has been shown to reduce the cerebral damage and neurologic deficit in ischemic conditions. A randomized controlled study based on a rabbit model was designed to study the effect of carbamazepine on a spinal cord ischemic reperfusion injury.